Division of Experimental Oncology

Director: Angelo Corti
Deputy Director: Paolo Ghia

Oncology bears a particular potential for translating research findings from the laboratory into clinical applications. Innovative strategies are urgently needed in the areas of diagnosis, patient risk stratification and treatment. The focus of the Division is to develop translational research programmes and clinical research. The tenet of the Division’s plans is that any significant progress toward the cure of cancer can only be based on an improved understanding of its pathogenesis, which, in turn, will lead to the development of improved diagnostics and more rationale therapeutic interventions.
Accordingly the Division is organized into 14 Units of Basic Research (URB) and 16 Groups of Clinical Research (GRC) with a total number of over 130 scientists including clinician-scientists. Extensive collaborations and joint activities will accelerate the implementation of translational research through access to a large number of patients and samples and combined resource platforms.
The Division is joining efforts with the Clinical Departments of Onco-Hematology and Oncology to create a virtual cancer center with a network organization, multidisciplinary teams and defined programs for different tumors and takes advantage of the collaborative use of resources, platforms and infrastructures with other Research Divisions and facilities.

Three major areas of investigation have been identified:

  • Cancer Genetics;
  • Cancer Microenvironment;
  • Cancer Immunology and Immunotherapy.

Three scientific programs have been so far planned:


Research units/clinic research groups